Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2025-12-25 @ 12:27 AM
NCT ID:
NCT00031967
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed solid tumor with brain metastasis
* No germ cell tumors
* RPA class II with any of the following:
* At least 65 years of age
* Extracranial metastases
* Uncontrolled primary malignancy
* Ineligible for or unwilling to participate in alternative RTOG stereotactic radiosurgery studies
PATIENT CHARACTERISTICS:
Age:
* See Disease Characteristics
Performance status:
* Zubrod 0-1
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* Able to swallow pills
* Not pregnant
* Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* More than 30 days since prior chemotherapy
* Concurrent chemotherapy after whole brain irradiation allowed
Endocrine therapy:
* Not specified
Radiotherapy:
* See Disease Characteristics
* No prior radiotherapy to the brain
Surgery:
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Years
Maximum Age:
120 Years
Study:
NCT00031967
Study Brief:
Protocol Section:
NCT00031967